Status:
RECRUITING
Post Market Registry for GORE® TAG® Thoracic Branch Endoprosthesis
Lead Sponsor:
W.L.Gore & Associates
Conditions:
Aneurysm
Dissection, Aortic
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to collect mid-term post-market clinical follow-up data of GORE® TAG® Thoracic Branch Endoprosthesis used according to the standard medical practice in patients...
Detailed Description
The purpose of the GORE® TAG® Thoracic Branch Endoprosthesis Registry is to collect real-world data for this device. Due to the nature of the registry, patient selection, diagnostic imaging, and treat...
Eligibility Criteria
Inclusion
- Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements Patient has been or is intended to be treated with an eligible registry device Patient is age ≥ 18 years at time of informed consent signature.
Exclusion
- Patient who is, at the time of consent, unlikely to be available for standard of care (SOC) follow-up visits as defined by the site's guidelines and procedures.
- Patient with exclusion criteria required by local law. Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study within 12 months of Together Registry enrollment. Subjects cannot be enrolled in another Together Registry module protocol.
Key Trial Info
Start Date :
February 20 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2031
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06507865
Start Date
February 20 2025
End Date
April 1 2031
Last Update
May 9 2025
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Medizinische Universität Wien
Vienna, Austria, A-1090
2
Rigshospitalet University Hospital
Copenhagen, Denmark, 2100
3
Universitätsklinikum Carl Gustav Carus Dresden
Dresden, Germany, 01307
4
University of Heidelberg
Heidelberg, Germany, 69120